Cullinan Therapeutics, Inc. CGEM Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s other operating expenses?
- Cullinan Therapeutics, Inc. (CGEM) reported other operating expenses of $53.7M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Cullinan Therapeutics, Inc.'s other operating expenses decreased by 2.4% year-over-year, from $55M to $53.7M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s other operating expenses has grown at a 29.1% compound annual growth rate (CAGR), from $86.9M to $241.65M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.